CHARLOTTE CSUNCHARLOTTE C SUN8695SUN, CHARLOTTE CAssociate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25242233Brown J, Taylor K, Ramirez PT, Sun C, Holman LL, Cone SM, Irwin J, Frumovitz MJournal of minimally invasive gynecologyLaparoscopic supracervical hysterectomy with morcellation: should it stay or should it go? J Minim Invasive Gynecol. 2015 Feb; 22(2):185-92.J Minim Invasive Gynecol2014-09-19T00:00:002014Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go?1155 Pressler StHouston77030-3721TXAuthorship 1739653Authorship 1749852Authorship 1751693Authorship 1764661Authorship 1765242Authorship 1772092Authorship 1778862Authorship 1779466Authorship 1779872Authorship 1780325Authorship 1781333Authorship 1784035Authorship 1787432Authorship 1795702Authorship 1802486Authorship 1804054Authorship 1804932Authorship 1817052Authorship 1823882Authorship 1829653Authorship 1831632Authorship 1833083Authorship 1848035Authorship 1856382Authorship 1857226Authorship 1858474Authorship 1859934Authorship 1862662Authorship 1869145Authorship 1878853Authorship 1886143Authorship 1892684Authorship 1900783Authorship 1904654Authorship 1907183Authorship 1925501415291996Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KHObstetrics and gynecologyDoes tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstet Gynecol. 2004 Aug; 104(2):255-60.Obstet Gynecol2004-08-01T00:00:002004Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?15882895Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback CGynecologic oncologyPhase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4.Gynecol Oncol2005-06-01T00:00:002005Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.16051336Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KHGynecologic oncologyEndometrial cancer in young, normal-weight women. Gynecol Oncol. 2005 Nov; 99(2):388-92.Gynecol Oncol2005-07-26T00:00:002005Endometrial cancer in young, normal-weight women.17292461Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, Gershenson DMGynecologic oncologyLack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Gynecol Oncol. 2007 May; 105(2):404-8.Gynecol Oncol2007-02-09T00:00:002007Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary.17511115Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DBSurgeryThe learning curve in pancreatic surgery. Surgery. 2007 May; 141(5):694-701.Surgery2007-05-01T00:00:002007The learning curve in pancreatic surgery.17892451Du XL, Sun CC, Milam MR, Bodurka DC, Fang SInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyEthnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. Int J Gynecol Cancer. 2008 Jul-Aug; 18(4):660-9.Int J Gynecol Cancer2007-09-24T00:00:002007Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.18155273Schmeler KM, Sun CC, Bodurka DC, Deavers MT, Malpica A, Coleman RL, Ramirez PT, Gershenson DMGynecologic oncologyNeoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2008 Mar; 108(3):510-4.Gynecol Oncol2007-12-26T00:00:002007Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.18506736Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KHCancerCost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer. 2008 Jul 15; 113(2):326-35.Cancer2008-07-15T00:00:002008Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.19241422Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke TCancerPhase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.Cancer2009-05-01T00:00:002009Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.19841329Kwon JS, Daniels MS, Sun CC, Lu KHJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreventing future cancers by testing women with ovarian cancer for BRCA mutations. J Clin Oncol. 2010 Feb 01; 28(4):675-82.J Clin Oncol2009-10-19T00:00:002009Preventing future cancers by testing women with ovarian cancer for BRCA mutations.Gynecological Oncology & Reproductive MedicinePalliative Care & Rehabilitation MedicineMD AndersonPEDRO TOMASRAMIREZPEDRO TOMAS RAMIREZ8779RAMIREZ, PEDRO TOMASProfessorDIANE CBODURKADIANE C BODURKA8604BODURKA, DIANE CProfessor4.311670.00613692507research areas5.457240.016195693coauthor of231.25723.105160similar to11187selected publicationsEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorKAREN HLUKAREN H LU8836LU, KAREN HProfessorROBERTCOLEMANROBERT COLEMAN9184COLEMAN, ROBERTProfessorLOIS MRAMONDETTALOIS M RAMONDETTA8743RAMONDETTA, LOIS MProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorSHANNON NEVILLEWESTINSHANNON NEVILLE WESTIN9337WESTIN, SHANNON NEVILLEAssociate ProfessorLARISSA ALEJANDRAMEYERLARISSA ALEJANDRA MEYER9431MEYER, LARISSA ALEJANDRAAssistant ProfessorAuthorship 2167042Authorship 2196177Authorship 2213311Authorship 2215108Authorship 22216112Authorship 2222367Authorship 2238512Authorship 2246261Authorship 2278219Authorship 2282484Authorship 2286122Authorship 2297136Authorship 2301894Authorship 2303485Authorship 2305454Authorship 2329575Authorship 2335542Authorship 2342533Authorship 2346693Authorship 235340410529029Cantor SB, Sun CC, Tortolero-Luna G, Richards-Kortum R, Follen MJournal of clinical epidemiologyA comparison of C/B ratios from studies using receiver operating characteristic curve analysis. J Clin Epidemiol. 1999 Sep; 52(9):885-92.J Clin Epidemiol1999-09-01T00:00:001999A comparison of C/B ratios from studies using receiver operating characteristic curve analysis.12910520Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DMCancerExpression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer. 2003 Aug 15; 98(4):758-64.Cancer2003-08-15T00:00:002003Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.15168104Smith JA, Kindo CC, Kurian S, Whitaker LM, Burke C, Wachel B, Sun CC, Weaver CL, Danielson MG, Fitzgerald MA, Munsell M, Zandstra FA, Bodurka DCSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerEvaluation of patient chemotherapy education in a gynecology oncology center. Support Care Cancer. 2004 Aug; 12(8):577-83.Support Care Cancer2004-05-28T00:00:002004Evaluation of patient chemotherapy education in a gynecology oncology center.15538640Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EBSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerRankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer. 2005 Apr; 13(4):219-27.Support Care Cancer2004-11-09T00:00:002004Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.15585381Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DBJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractPancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004 Dec; 8(8):935-49; discussion 949-50.J Gastrointest Surg2004-12-01T00:00:002004Pancreaticoduodenectomy with vascular resection: margin status and survival duration.15738026Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RRObstetrics and gynecologyGynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74.Obstet Gynecol2005-03-01T00:00:002005Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.17183353Sun CC, Ramirez PT, Bodurka DCNature clinical practice. OncologyQuality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol. 2007 Jan; 4(1):18-29.Nat Clin Pract Oncol2007-01-01T00:00:002007Quality of life for patients with epithelial ovarian cancer.17320156Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DMGynecologic oncologyComparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Gynecol Oncol. 2007 Jun; 105(3):625-9.Gynecol Oncol2007-02-22T00:00:002007Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.18640929Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DBJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008 Jul 20; 26(21):3487-95.J Clin Oncol2008-07-20T00:00:002008Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.20162463Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DBAnnals of surgical oncologySerum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol. 2010 Jul; 17(7):1794-801.Ann Surg Oncol2010-02-17T00:00:002010Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.20733129Kwon JS, Gutierrez-Barrera AM, Young D, Sun CC, Daniels MS, Lu KH, Arun BJournal of clinical oncology : official journal of the American Society of Clinical OncologyExpanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol. 2010 Sep 20; 28(27):4214-20.J Clin Oncol2010-08-23T00:00:002010Expanding the criteria for BRCA mutation testing in breast cancer survivors.20802181Wong KK, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, Malpica A, Wolf JK, Lu KH, Gershenson DMThe American journal of pathologyBRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol. 2010 Oct; 177(4):1611-7.Am J Pathol2010-08-27T00:00:002010BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.21319148Schlumbrecht MP, Sun CC, Wong KN, Broaddus RR, Gershenson DM, Bodurka DCCancerClinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma. Cancer. 2011 Aug 15; 117(16):3741-9.Cancer2011-02-11T00:00:002011Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma.21436700Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LMInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyA phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011 Apr; 21(3):517-22.Int J Gynecol Cancer2011-04-01T00:00:002011A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma.21537049Kwon JS, Scott JL, Gilks CB, Daniels MS, Sun CC, Lu KHJournal of clinical oncology : official journal of the American Society of Clinical OncologyTesting women with endometrial cancer to detect Lynch syndrome. J Clin Oncol. 2011 Jun 01; 29(16):2247-52.J Clin Oncol2011-05-02T00:00:002011Testing women with endometrial cancer to detect Lynch syndrome.23760948Huang M, Djordjevic B, Yates MS, Urbauer D, Sun C, Burzawa J, Daniels M, Westin SN, Broaddus R, Lu KCancerMolecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Cancer. 2013 Aug 15; 119(16):3027-33.Cancer2013-06-12T00:00:002013Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.23775154Ramondetta LM, Sun C, Surbone A, Olver I, Ripamonti C, Konishi T, Baider L, Johnson JSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerSurprising results regarding MASCC members' beliefs about spiritual care. Support Care Cancer. 2013 Nov; 21(11):2991-8.Support Care Cancer2013-06-18T00:00:002013Surprising results regarding MASCC members' beliefs about spiritual care.24257567Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyProspective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly cisplatin or every-3-week cisplatin and 5-fluorouracil. Int J Gynecol Cancer. 2013 Oct; 23(8):1520-7.Int J Gynecol Cancer2013-10-01T00:00:002013Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly cisplatin or every-3-week cisplatin and 5-fluorouracil.24549645Tsang YT, Deavers MT, Sun CC, Kwan SY, Kuo E, Malpica A, Mok SC, Gershenson DM, Wong KKThe Journal of pathologyKRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol. 2013 Dec; 231(4):449-56.J Pathol2013-12-01T00:00:002013KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.24857045Solheim O, Gershenson DM, Trop? CG, Rokkones E, Sun CC, Weedon-Fekjaer H, Foss? SDEuropean journal of cancer (Oxford, England : 1990)Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010). Eur J Cancer. 2014 Jul; 50(11):1942-50.Eur J Cancer2014-05-20T00:00:002014Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).Authorship 2420392Authorship 2456496Authorship 2469893Authorship 2473944Authorship 2476652Authorship 2478524Authorship 2496676Authorship 2497967Authorship 2514776Authorship 2526053Authorship 2526682Authorship 2531453Authorship 2532664Authorship 2550493Authorship 2552993Authorship 2557872Authorship 2559428Authorship 2561203Authorship 2577348Authorship 2591942Authorship 2593665Authorship 2609558Authorship 261483710926809Robinson JB, Sun CC, Bodurka-Bevers D, Im DD, Rosenshein NBGynecologic oncologyCavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia. Gynecol Oncol. 2000 Aug; 78(2):235-41.Gynecol Oncol2000-08-01T00:00:002000Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia.14766251Schimp VL, Worley C, Brunello S, Levenback CC, Wolf JK, Sun CC, Bodurka DC, Ramirez PTGynecologic oncologyVacuum-assisted closure in the treatment of gynecologic oncology wound failures. Gynecol Oncol. 2004 Feb; 92(2):586-91.Gynecol Oncol2004-02-01T00:00:002004Vacuum-assisted closure in the treatment of gynecologic oncology wound failures.15738027Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KHObstetrics and gynecologyRisk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005 Mar; 105(3):575-80.Obstet Gynecol2005-03-01T00:00:002005Risk factors for young premenopausal women with endometrial cancer.16014119Tangjitgamol S, Ramirez PT, Sun CC, See HT, Jhingran A, Kavanagh JJ, Deavers MTInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyExpression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer. 2005 Jul-Aug; 15(4):646-56.Int J Gynecol Cancer2005-07-01T00:00:002005Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.16516276Wolf JK, Bodurka DC, Verschraegen C, Sun CC, Branham D, Jenkins AD, Atkinson N, Gershenson DMGynecologic oncologyA phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer. Gynecol Oncol. 2006 Sep; 102(3):468-74.Gynecol Oncol2006-03-03T00:00:002006A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer.16855388Schmandt RE, Bennett M, Clifford S, Thornton A, Jiang F, Broaddus RR, Sun CC, Lu KH, Sood AK, Gershenson DMCancer biology & therapyThe BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. Cancer Biol Ther. 2006 Sep; 5(9):1136-41.Cancer Biol Ther2006-09-28T00:00:002006The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.16946209Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KHObstetrics and gynecologyProphylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):515-20.Obstet Gynecol2006-09-01T00:00:002006Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.17383522Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DBSurgeryThe learning curve in pancreatic surgery. Surgery. 2007 Apr; 141(4):456-63.Surgery2007-01-22T00:00:002007The learning curve in pancreatic surgery.18310380Westin SN, Bustillos D, Gano JB, Fields MM, Coker AL, Sun CC, Ramondetta LMObstetrics and gynecologySocial factors affecting treatment of cervical cancer: ethical issues and policy implications. Obstet Gynecol. 2008 Mar; 111(3):747-51.Obstet Gynecol2008-03-01T00:00:002008Social factors affecting treatment of cervical cancer: ethical issues and policy implications.18337438Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JAJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersComparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. J Oncol Pharm Pract. 2008 Mar; 14(1):31-6.J Oncol Pharm Pract2008-03-01T00:00:002008Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics.19194760Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DBAnnals of surgical oncologyLong-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009 Apr; 16(4):836-47.Ann Surg Oncol2009-02-05T00:00:002009Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.19361839Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJGynecologic oncologyRecurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol. 2009 Jul; 114(1):48-52.Gynecol Oncol2009-04-10T00:00:002009Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.20186516Ready KJ, Daniels MS, Sun CC, Peterson SK, Northrup H, Lu KHJournal of cancer education : the official journal of the American Association for Cancer EducationObstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome. J Cancer Educ. 2010 Sep; 25(3):401-4.J Cancer Educ2010-09-01T00:00:002010Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome.20835927Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DCJournal of cancer education : the official journal of the American Association for Cancer EducationEthics consultation on a gynecologic oncology service: an opportunity for physician education. J Cancer Educ. 2011 Mar; 26(1):183-7.J Cancer Educ2011-03-01T00:00:002011Ethics consultation on a gynecologic oncology service: an opportunity for physician education.21265391Avritscher EB, Shih YC, Sun CC, Gralla RJ, Grunberg SM, Xu Y, Elting LSThe journal of supportive oncologyCost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients. J Support Oncol. 2010 Nov-Dec; 8(6):242-51.J Support Oncol2010-11-01T00:00:002010Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients.21294483Bodurka DC, Huang M, Sun CCOncology (Williston Park, N.Y.)Caring for cancer patients in the future: a perfect storm on the horizon? Oncology (Williston Park). 2010 Dec; 24(14):1351-2.Oncology (Williston Park)2010-12-01T00:00:002010Caring for cancer patients in the future: a perfect storm on the horizon?21436706Ramondetta L, Brown A, Richardson G, Urbauer D, Thaker PH, Koenig HG, Gano JB, Sun CInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyReligious and spiritual beliefs of gynecologic oncologists may influence medical decision making. Int J Gynecol Cancer. 2011 Apr; 21(3):573-81.Int J Gynecol Cancer2011-04-01T00:00:002011Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making.21532810Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu KJournal of oncology practiceProspective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract. 2011 Jan; 7(1):43-7.J Oncol Pract2011-01-01T00:00:002011Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach.21777966Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun CGynecologic oncologyWork related stress among gynecologic oncologists. Gynecol Oncol. 2011 Nov; 123(2):365-9.Gynecol Oncol2011-07-20T00:00:002011Work related stress among gynecologic oncologists.23615044Williams LA, Agarwal S, Bodurka DC, Saleeba AK, Sun CC, Cleeland CSJournal of pain and symptom managementCapturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manage. 2013 Dec; 46(6):837-45.J Pain Symptom Manage2013-04-22T00:00:002013Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.23685012Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CSGynecologic oncologyValidating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8.Gynecol Oncol2013-05-15T00:00:002013Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.23707670Romero I, Sun CC, Wong KK, Bast RC, Gershenson DMGynecologic oncologyLow-grade serous carcinoma: new concepts and emerging therapies. Gynecol Oncol. 2013 Sep; 130(3):660-6.Gynecol Oncol2013-05-23T00:00:002013Low-grade serous carcinoma: new concepts and emerging therapies.24246524Holman LL, Lu KH, Bast RC, Hernandez MA, Bodurka DC, Skates S, Sun CCAmerican journal of obstetrics and gynecologyRisk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening. Am J Obstet Gynecol. 2014 Mar; 210(3):257.e1-6.Am J Obstet Gynecol2013-11-16T00:00:002013Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening.25519758Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LMSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerTargeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32.Support Care Cancer2014-12-18T00:00:002014Targeting those with decreased meaning and peace: a supportive care opportunity.Authorship 2651302Authorship 26682913Authorship 2668495Authorship 2672882Authorship 2681354Authorship 2693744Authorship 2699122Authorship 2699427Authorship 270393210947337Bodurka-Bevers D, Sun CC, Gershenson DMPharmacoEconomicsPharmacoeconomic considerations in treating ovarian cancer. Pharmacoeconomics. 2000 Feb; 17(2):133-50.Pharmacoeconomics2000-02-01T00:00:002000Pharmacoeconomic considerations in treating ovarian cancer.16421367Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KHThe New England journal of medicineProphylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006 Jan 19; 354(3):261-9.N Engl J Med2006-01-19T00:00:002006Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.17116505Bodurka DC, Sun CCObstetrics and gynecology clinics of North AmericaSexual function after gynecologic cancer. Obstet Gynecol Clin North Am. 2006 Dec; 33(4):621-30, ix.Obstet Gynecol Clin North Am2006-12-01T00:00:002006Sexual function after gynecologic cancer.17925543Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM, Broaddus RRJournal of clinical oncology : official journal of the American Society of Clinical OncologyProspective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol. 2007 Nov 20; 25(33):5158-64.J Clin Oncol2007-10-09T00:00:002007Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.18471707Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RFJournal of the American College of SurgeonsBorderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2008 May; 206(5):833-46; discussion 846-8.J Am Coll Surg2008-03-17T00:00:002008Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.19280625Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BKCancerPerception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer. 2009 Apr 15; 115(8):1598-604.Cancer2009-04-15T00:00:002009Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.21397305Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DMGynecologic oncologyLow-grade serous primary peritoneal carcinoma. Gynecol Oncol. 2011 Jun 01; 121(3):482-6.Gynecol Oncol2011-03-11T00:00:002011Low-grade serous primary peritoneal carcinoma.21656744Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DCCancerSatisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer. 2011 Jun 15; 117(12):2659-67.Cancer2010-12-29T00:00:002010Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.21681553Ready K, Arun BK, Schmeler KM, Uyei A, Litton JK, Lu KH, Sun CC, Peterson SKFamilial cancerCommunication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center. Fam Cancer. 2011 Dec; 10(4):673-9.Fam Cancer2011-12-01T00:00:002011Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.Authorship 2727947Authorship 2731182Authorship 2733283Authorship 2741024Authorship 2743472Authorship 2743572Authorship 2752734Authorship 2771691Authorship 277413412468352Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DMGynecologic oncologyPatient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecol Oncol. 2002 Oct; 87(1):118-28.Gynecol Oncol2002-10-01T00:00:002002Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?15284264Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KHJournal of clinical oncology : official journal of the American Society of Clinical OncologyHer-2/neu overexpression and amplification in uterine papillary serous carcinoma. J Clin Oncol. 2004 Aug 01; 22(15):3126-32.J Clin Oncol2004-08-01T00:00:002004Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.15297188Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KHGynecologic oncologySynchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004 Aug; 94(2):456-62.Gynecol Oncol2004-08-01T00:00:002004Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.16880307Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DCObstetrics and gynecologyClinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol. 2006 Aug; 108(2):361-8.Obstet Gynecol2006-08-01T00:00:002006Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.17592291Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DBAnnals of surgeryImpact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007 Jul; 246(1):52-60.Ann Surg2007-07-01T00:00:002007Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.22072418Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson RE, Steinhoff M, Behmaram B, Rasty G, Gershenson DMCancerReclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer. 2012 Jun 15; 118(12):3087-94.Cancer2011-11-09T00:00:002011Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.22387451Noguera IR, Sun CC, Broaddus RR, Branham D, Levenback CF, Ramirez PT, Sood AK, Coleman RL, Gershenson DMGynecologic oncologyPhase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube. Gynecol Oncol. 2012 Jun; 125(3):640-5.Gynecol Oncol2012-02-28T00:00:002012Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube.22406638Gershenson DM, Sun CC, Iyer RB, Malpica AL, Kavanagh JJ, Bodurka DC, Schmeler K, Deavers MGynecologic oncologyHormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2012 Jun; 125(3):661-6.Gynecol Oncol2012-03-06T00:00:002012Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.24582866Holman LL, Friedman S, Daniels MS, Sun CC, Lu KHGynecologic oncologyAcceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecol Oncol. 2014 May; 133(2):283-6.Gynecol Oncol2014-02-28T00:00:002014Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.Authorship 2789692Authorship 2791736Authorship 2795504Authorship 2888431Authorship 2893208Authorship 2910122Authorship 2924962Authorship 2925096Authorship 2962952Authorship 2970898Authorship 29955010Authorship 3007575Authorship 3010782Authorship 303583223906188Burton-Chase AM, Hovick SR, Sun CC, Boyd-Rogers S, Lynch PM, Lu KH, Peterson SKClinical geneticsGynecologic cancer screening and communication with health care providers in women with Lynch syndrome. Clin Genet. 2014 Aug; 86(2):185-9.Clin Genet2013-08-27T00:00:002013Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome.24469324Schlumbrecht MP, Sun CC, Huang MS, Zandstra F, Bodurka DCInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyLifestyle modification in cervical cancer survivors: an ongoing need. Int J Gynecol Cancer. 2014 Mar; 24(3):570-5.Int J Gynecol Cancer2014-03-01T00:00:002014Lifestyle modification in cervical cancer survivors: an ongoing need.24771847Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RRCancer prevention research (Philadelphia, Pa.)Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. Cancer Prev Res (Phila). 2014 Jul; 7(7):686-97.Cancer Prev Res (Phila)2014-04-25T00:00:002014Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.25192878Brown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DCGynecologic oncologyMissed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients. Gynecol Oncol. 2014 Nov; 135(2):244-8.Gynecol Oncol2014-09-02T00:00:002014Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients.25448453Crane EK, Sun CC, Ramirez PT, Schmeler KM, Malpica A, Gershenson DMGynecologic oncologyThe role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer. Gynecol Oncol. 2015 Jan; 136(1):25-9.Gynecol Oncol2014-11-08T00:00:002014The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer.25451693Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DCGynecologic oncologyPerioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol. 2015 Jan; 136(1):65-70.Gynecol Oncol2014-11-14T00:00:002014Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database.25988961Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LMGynecologic oncologyFeeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients. Gynecol Oncol. 2015 Aug; 138(2):388-93.Gynecol Oncol2015-05-16T00:00:002015Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.26195696Gershenson DM, Bodurka DC, Lu KH, Nathan LC, Milojevic L, Wong KK, Malpica A, Sun CCJournal of clinical oncology : official journal of the American Society of Clinical OncologyImpact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor. J Clin Oncol. 2015 Aug 20; 33(24):2675-82.J Clin Oncol2015-07-20T00:00:002015Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.26197762Arms RG, Sun CC, Burzawa JK, Fleming ND, Nick AM, Rallapalli V, Westin SN, Meyer LA, Ramirez PT, Soliman PTGynecologic oncologyImprovement in quality of life after robotic surgery results in patient satisfaction. Gynecol Oncol. 2015 Sep; 138(3):727-30.Gynecol Oncol2015-07-18T00:00:002015Improvement in quality of life after robotic surgery results in patient satisfaction.26432043Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LMGynecologic oncologyRetrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):553-8.Gynecol Oncol2015-09-30T00:00:002015Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer.26484411Gershenson DM, Sun CC, Wong KKBritish journal of cancerImpact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum. Br J Cancer. 2015 Nov 03; 113(9):1254-8.Br J Cancer2015-10-20T00:00:002015Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum.26498912Ramondetta LM, Meyer LA, Schmeler KM, Daheri ME, Gallegos J, Scheurer M, Montealegre JR, Milbourne A, Anderson ML, Sun CCGynecologic oncologyAvoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):500-5.Gynecol Oncol2015-10-21T00:00:002015Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.15325608Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DCJournal of the American College of SurgeonsFrozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004 Sep; 199(3):388-93.J Am Coll Surg2004-09-01T00:00:002004Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.74Professor10Assistant Professor14Associate Professor16234510Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DCJournal of clinical oncology : official journal of the American Society of Clinical OncologyQuality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.J Clin Oncol2005-10-20T00:00:002005Quality of life and sexual functioning in cervical cancer survivors.26245979Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DCJournal of cancer survivorship : research and practiceSurvivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016 Apr; 10(2):261-70.J Cancer Surviv2015-08-06T00:00:002015Survivors of gynecologic malignancies: impact of treatment on health and well-being.15378473Tseng JF, Kronowitz SJ, Sun CC, Perry AC, Hunt KK, Babiera GV, Newman LA, Singletary SE, Mirza NQ, Ames FC, Meric-Bernstam F, Ross MI, Feig BW, Robb GL, Kuerer HMCancerThe effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004 Oct 01; 101(7):1514-23.Cancer2004-10-01T00:00:002004The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer.16221383Sun CC, Frumovitz M, Bodurka DCCurrent oncology reportsQuality of life and gynecologic malignancies. Curr Oncol Rep. 2005 Nov; 7(6):459-65.Curr Oncol Rep2005-11-01T00:00:002005Quality of life and gynecologic malignancies.15385122Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback CGynecologic oncologyHormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004 Oct; 95(1):133-8.Gynecol Oncol2004-10-01T00:00:002004Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.16551476Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DCGynecologic oncologyAre women ready for the HPV vaccine? Gynecol Oncol. 2006 Oct; 103(1):151-4.Gynecol Oncol2006-03-21T00:00:002006Are women ready for the HPV vaccine?Authorship 374206322240566Worley MJ, Anwandter C, Sun CC, dos Reis R, Nick AM, Frumovitz M, Soliman PT, Schmeler KM, Levenback CF, Munsell MF, Ramirez PTGynecologic oncologyImpact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4.Gynecol Oncol2012-01-10T00:00:002012Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery.17035002Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback CSurgical oncologyRetroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.Surg Oncol2006-10-10T00:00:002006Retroperitoneal lymph node resection in patients with cervical cancer.18640930Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RAJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008 Jul 20; 26(21):3496-502.J Clin Oncol2008-07-20T00:00:002008Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.19546764Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Dos Reis R, Levenback CF, Ramirez PTObstetrics and gynecologyParametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-99.Obstet Gynecol2009-07-01T00:00:002009Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.19765809Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DCGynecologic oncologySurvival after intestinal perforation: can it be predicted? Gynecol Oncol. 2009 Dec; 115(3):349-53.Gynecol Oncol2009-09-18T00:00:002009Survival after intestinal perforation: can it be predicted?20052724Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AKCancerPelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.Cancer2010-02-01T00:00:002010Pelvic fractures after radiotherapy for cervical cancer: implications for survivors.20431955Brandt AC, Tschirgi ML, Ready KJ, Sun C, Darilek S, Hecht J, Arun BK, Lu KHFamilial cancerKnowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes. Fam Cancer. 2010 Sep; 9(3):479-87.Fam Cancer2010-09-01T00:00:002010Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes.21126756Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KHGynecologic oncologyIs low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer? Gynecol Oncol. 2011 Feb; 120(2):229-32.Gynecol Oncol2010-12-03T00:00:002010Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?21872911Soliman PT, Frumovitz M, Sun CC, Dos Reis R, Schmeler KM, Nick AM, Westin SN, Brown J, Levenback CF, Ramirez PTGynecologic oncologyRadical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.Gynecol Oncol2011-08-27T00:00:002011Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology.21099603Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PTObstetrics and gynecologyPrimary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365.Obstet Gynecol2010-12-01T00:00:002010Primary malignant melanoma of the vagina.21178574Agarwal S, Schmeler KM, Ramirez PT, Sun CC, Nick A, Dos Reis R, Brown J, Frumovitz MInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyOutcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. Int J Gynecol Cancer. 2011 Jan; 21(1):123-7.Int J Gynecol Cancer2011-01-01T00:00:002011Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes.22353948Frumovitz M, Kriseman ML, Sun CC, Blumenthal-Barby J, Sood AK, Bodurka DC, Soliman PTObstetrics and gynecologyUnverifiable accomplishments and publications on applications for gynecologic oncology fellowships. Obstet Gynecol. 2012 Mar; 119(3):504-8.Obstet Gynecol2012-03-01T00:00:002012Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships.Authorship 844284Authorship 844919Authorship 847693Authorship 851047Authorship 854534Authorship 856290Authorship 856552Authorship 856643Authorship 860061Authorship 863486Authorship 864274Authorship 864503Authorship 865087Authorship 865780Authorship 867288OncologyGynecologic cancer survivors. Oncology. 21:608-609.Gynecologic cancer survivorsJournal of Cancer SurvivorshipSurvivors of gynecologic malignancies. Journal of Cancer Survivorship. Survivors of gynecologic malignanciesObstetrical and Gynecological SurveyUse of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer. Obstetrical and Gynecological Survey. 71:660-661.Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancerGynecologic cancer survivorship management. 125-143.Gynecologic cancer survivorship managementBritish Journal of CancerImpact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum. British Journal of Cancer. 113:1254-1258.Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneumOncologyCaring for cancer patients in the future. Oncology. 24.Caring for cancer patients in the futureJournal of Clinical OncologyUse and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer. Journal of Clinical Oncology. 34:3854-3863.Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancerJournal of Women's HealthEndometrial Cancer Associated Symptoms. Journal of Women's Health. 25:1187-1192.Endometrial Cancer Associated SymptomsGynecologic OncologyRoom for improvement. Gynecologic Oncology. 142:525-530.Room for improvementAnnals of Surgical OncologyThe DISINFECT Initiative. Annals of Surgical Oncology. 1-7.The DISINFECT InitiativeGynecologic OncologyDying well. Gynecologic Oncology. Dying wellOncology (Switzerland)Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN. Oncology (Switzerland). 109-114.Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTENQuality of Life in the Gynecologic Cancer Patient. 785-794.Quality of Life in the Gynecologic Cancer PatientObstetrical and Gynecological SurveyEvaluation of clinical criteria for the identification of lynch syndrome among unselected endometrial cancer patients. Obstetrical and Gynecological Survey. 69:541-542.Evaluation of clinical criteria for the identification of lynch syndrome among unselected endometrial cancer patientsAbdominal RadiologyIncrease in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer. Abdominal Radiology. 41:1589-1595.Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer15863122Bodurka DC, Sun CC, Frumovitz MMGynecologic oncologyQuality of life in cervix cancer survivors--what matters the most in the long-term? Gynecol Oncol. 2005 May; 97(2):307-9.Gynecol Oncol2005-05-01T00:00:002005Quality of life in cervix cancer survivors--what matters the most in the long-term?16639738Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, Bodurka DCCancerGeneralizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 2006 Jun 01; 106(11):2452-8.Cancer2006-06-01T00:00:002006Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants.16730784Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown JGynecologic oncologyAdvanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol. 2006 Nov; 103(2):547-53.Gynecol Oncol2006-05-30T00:00:002006Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy.17601902Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW, Brown J, Slomovitz BM, Ramirez PTObstetrics and gynecologyComparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol. 2007 Jul; 110(1):96-102.Obstet Gynecol2007-07-01T00:00:002007Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer.17854872dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PTGynecologic oncologyAdenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007 Dec; 107(3):458-63.Gynecol Oncol2007-09-12T00:00:002007Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.18827134Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PTObstetrics and gynecologyRadical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct; 112(4):899-905.Obstet Gynecol2008-10-01T00:00:002008Radical hysterectomy in obese and morbidly obese women with cervical cancer.20664385Schmeler KM, Tao X, Frumovitz M, Deavers MT, Sun CC, Sood AK, Brown J, Gershenson DM, Ramirez PTObstetrics and gynecologyPrevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol. 2010 Aug; 116(2 Pt 1):269-273.Obstet Gynecol2010-08-01T00:00:002010Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary.Authorship 8874792D005833Disorders1887340.597618Genital Neoplasms, FemaleD018284Disorders1224860.711014Cystadenocarcinoma, SerousD010051Disorders61946210.31574Ovarian NeoplasmsAuthorship 9041674Authorship 9056916Authorship 9077474Authorship 9077563Authorship 9079814Authorship 9080453Authorship 9130783Authorship 9132893Authorship 9134053Authorship 9136863Authorship 9181762Authorship 92345511Authorship 9266944Authorship 9272674Authorship 9282537Authorship 9284212Authorship 9287887Authorship 9291063Authorship 9321241Authorship 933364526969496Ganeshan D, Bhosale P, Wei W, Ramalingam P, Mudasiru-Dawodu E, Gershenson D, Sun C, Iyer RAbdominal radiology (New York)Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer. Abdom Radiol (NY). 2016 08; 41(8):1589-95.Abdom Radiol (NY)2016-08-01T00:00:002016Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.26706661Taylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DCGynecologic oncologyDying well: How equal is end of life care among gynecologic oncology patients? Gynecol Oncol. 2016 Feb; 140(2):295-300.Gynecol Oncol2015-12-17T00:00:002015Dying well: How equal is end of life care among gynecologic oncology patients?27439968Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DCGynecologic oncologyRoom for improvement: An examination of advance care planning documentation among gynecologic oncology patients. Gynecol Oncol. 2016 09; 142(3):525-30.Gynecol Oncol2016-07-18T00:00:002016Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients.27442965Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AAJAMA oncologyUse of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncol. 2016 Nov 01; 2(11):1427-1433.JAMA Oncol2016-11-01T00:00:002016Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.27573526Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KMAnnals of surgical oncologyThe DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol. 2017 Feb; 24(2):362-368.Ann Surg Oncol2016-08-29T00:00:002016The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology.27254529Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PTJournal of women's health (2002)Endometrial Cancer Associated Symptoms: A Case-Control Study. J Womens Health (Larchmt). 2016 11; 25(11):1187-1192.J Womens Health (Larchmt)2016-06-02T00:00:002016Endometrial Cancer Associated Symptoms: A Case-Control Study.28139261Dalton HJ, Fleming ND, Sun CC, Bhosale P, Schmeler KM, Gershenson DMGynecologic oncologyActivity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience. Gynecol Oncol. 2017 04; 145(1):37-40.Gynecol Oncol2017-01-27T00:00:002017Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience.28131529Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LAGynecologic oncologyImpact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017 04; 145(1):55-60.Gynecol Oncol2017-01-26T00:00:002017Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.27931017Iglesias DA, Zhang Q, Celestino J, Sun CC, Yates MS, Schmandt RE, Lu KHOncologyLean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN. Oncology. 2017; 92(2):109-114.Oncology2016-12-09T00:00:002016Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.28175997Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LMSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerNothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Support Care Cancer. 2017 06; 25(6):1985-1991.Support Care Cancer2017-02-07T00:00:002017Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients.27601552Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyUse and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 11 10; 34(32):3854-3863.J Clin Oncol2016-11-10T00:00:002016Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.28221866Gershenson DM, Bodurka DC, Coleman RL, Lu KH, Malpica A, Sun CCJournal of clinical oncology : official journal of the American Society of Clinical OncologyHormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum. J Clin Oncol. 2017 Apr 01; 35(10):1103-1111.J Clin Oncol2017-02-21T00:00:002017Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.28610746Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KHGynecologic oncologyA universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment. Gynecol Oncol. 2017 08; 146(2):399-404.Gynecol Oncol2017-06-10T00:00:002017A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.28528918Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KHGynecologic oncologyA prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239.Gynecol Oncol2017-05-18T00:00:002017A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.28399031Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DCInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyThe Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. Int J Gynecol Cancer. 2017 05; 27(4):838-846.Int J Gynecol Cancer2017-05-01T00:00:002017The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients.28574929Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyTreatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer. 2017 09; 27(7):1350-1359.Int J Gynecol Cancer2017-09-01T00:00:002017Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.28941656Shah JS, Guerra R, Bodurka DC, Sun CC, Chisholm GB, Woodard TLGynecologic oncologyFactors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members. Gynecol Oncol. 2017 12; 147(3):497-502.Gynecol Oncol2017-09-21T00:00:002017Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members.28787528Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Saglam O, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman LD, Sood AK, Gershenson DMJournal of surgical oncologyImpact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol. 2018 Feb; 117(2):236-244.J Surg Oncol2017-08-08T00:00:002017Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.29614979Schlumbrecht M, Sun C, Huang M, Milbourne A, Bodurka DBMC cancerGynecologic cancer survivor preferences for long-term surveillance. BMC Cancer. 2018 04 03; 18(1):375.BMC Cancer2018-04-03T00:00:002018Gynecologic cancer survivor preferences for long-term surveillance.29622276Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PTGynecologic oncologyProspective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol. 2018 06; 149(3):484-490.Gynecol Oncol2018-04-02T00:00:002018Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.29303933Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AHInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPerirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer. Int J Gynecol Cancer. 2018 02; 28(2):285-292.Int J Gynecol Cancer2018-02-01T00:00:002018Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer.29735278Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KHGynecologic oncologyBilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecol Oncol. 2018 07; 150(1):79-84.Gynecol Oncol2018-05-04T00:00:002018Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.30253875Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LAGynecologic oncologyDisparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol. 2018 11; 151(2):269-274.Gynecol Oncol2018-09-22T00:00:002018Disparities in treatment and survival among elderly ovarian cancer patients.29961559Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SHGynecologic oncologyNeoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol. 2018 09; 150(3):451-459.Gynecol Oncol2018-06-29T00:00:002018Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.30528888Bednar EM, Sun CC, Camacho B, Terrell J, Rieber AG, Ramondetta LM, Freedman RS, Lu KHGynecologic oncologyDisseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic. Gynecol Oncol. 2019 02; 152(2):328-333.Gynecol Oncol2018-12-08T00:00:002018Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.D010534Disorders2638130.599144Peritoneal NeoplasmsD002583Disorders34118390.444985Uterine Cervical NeoplasmsAuthorship 9416721Authorship 942061330876486Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LAGynecologic oncologyNational trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol. 2019 03; 152(3):439-444.Gynecol Oncol2019-03-01T00:00:002019National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.30876495Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH, Ramirez PTGynecologic oncologyComparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol. 2019 03; 152(3):501-508.Gynecol Oncol2019-03-01T00:00:002019Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.30876497Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SKGynecologic oncologyWomen's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol. 2019 03; 152(3):514-521.Gynecol Oncol2019-03-01T00:00:002019Women's preferences for cancer risk management strategies in Lynch syndrome.30906877Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GBExpert review of quality of life in cancer careThe management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016; 1(3):231-238.Expert Rev Qual Life Cancer Care2016-05-27T00:00:002016The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer.Authorship 943978229889752Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LAObstetrics and gynecologyThree Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol. 2018 07; 132(1):52-58.Obstet Gynecol2018-07-01T00:00:002018Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.Authorship 944693330965052Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyTotal and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol. 2019 08; 221(2):136.e1-136.e9.Am J Obstet Gynecol2019-04-06T00:00:002019Total and out-of-pocket costs of different primary management strategies in ovarian cancer.23983047Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, Fritsche H, Bast RCCancerA 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value. Cancer. 2013 Oct 01; 119(19):3454-61.Cancer2013-08-26T00:00:002013A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.Authorship 9477685Authorship 94819510Authorship 9482253Authorship 9482262Authorship 94829914Authorship 9483234Authorship 9483809Authorship 9483837Authorship 948470831128110Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyNational patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol. 2019 11; 221(5):474.e1-474.e11.Am J Obstet Gynecol2019-05-22T00:00:002019National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.24466566Eberth JM, Prarelkar P, Nguyen H, Sun C, Irvin-Vidrine J, Elting LSTexas public health journalThe Human and Economic Burden of Cervical Cancer in Texas. Tex Public Health J. 2013 Jan; 65(2):51-55.Tex Public Health J2013-01-01T00:00:002013The Human and Economic Burden of Cervical Cancer in Texas.Authorship 950082331208738Dottino JA, He W, Sun CC, Zhao H, Fu S, Lu KH, Meyer LAGynecologic oncologyCenters for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecol Oncol. 2019 08; 154(2):405-410.Gynecol Oncol2019-06-14T00:00:002019Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.Authorship 9627043Authorship 962895231843871Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyBody mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer. 2020 02; 30(2):187-192.Int J Gynecol Cancer2019-12-15T00:00:002019Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment.31857708Bednar EM, Sun CC, McCurdy S, Vernon SWGenetics in medicine : official journal of the American College of Medical GeneticsAssessing relatives' readiness for hereditary cancer cascade genetic testing. Genet Med. 2020 04; 22(4):719-726.Genet Med2019-12-20T00:00:002019Assessing relatives' readiness for hereditary cancer cascade genetic testing.Authorship 9762091031969252Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, Wong KK, Covens A, O'Malley DM, Lecuru F, Cobb LP, Caputo TA, May T, Huang M, Siemon J, Fern?ndez ML, Ray-Coquard I, Gershenson DMGynecologic oncologyLow-grade serous ovarian cancer: State of the science. Gynecol Oncol. 2020 03; 156(3):715-725.Gynecol Oncol2020-01-20T00:00:002020Low-grade serous ovarian cancer: State of the science.Authorship 993179332616627Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyNational trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020 08; 30(8):1195-1202.Int J Gynecol Cancer2020-07-02T00:00:002020National trends in bowel and upper abdominal procedures in ovarian cancer surgery.Authorship 995199232709538Cobb LP, Sun CC, Iyer R, Nick AM, Fleming ND, Westin SN, Sood AK, Wong KK, Silva EG, Gershenson DMGynecologic oncologyThe role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance. Gynecol Oncol. 2020 09; 158(3):653-658.Gynecol Oncol2020-07-22T00:00:002020The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance.Authorship 997316332805208Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, Lu KH, Bodurka DC, Coleman RL, Yates MSAmerican journal of obstetrics and gynecologyProspective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol. 2021 02; 224(2):191.e1-191.e15.Am J Obstet Gynecol2020-08-15T00:00:002020Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.Authorship 1002144333019983Gershenson DM, Cobb LP, Sun CCGynecologic oncologyEndocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors. Gynecol Oncol. 2020 12; 159(3):601-603.Gynecol Oncol2020-10-02T00:00:002020Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors.Authorship 1010538333536126Harrison RF, Cantor SB, Sun CC, Villanueva M, Westin SN, Fleming ND, Toumazis I, Sood AK, Lu KH, Meyer LAGynecologic oncologyCost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2021 04; 161(1):56-62.Gynecol Oncol2021-01-31T00:00:002021Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.Authorship 1010819333549538Harrison RF, Fu S, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyPatient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol. 2021 07; 225(1):68.e1-68.e11.Am J Obstet Gynecol2021-02-04T00:00:002021Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.Authorship 1014443233758374Bednar EM, Sun CC, McCurdy S, Vernon SWGenetics in medicine : official journal of the American College of Medical GeneticsResponse to Carlson. Genet Med. 2021 06; 23(6):1169-1170.Genet Med2021-03-23T00:00:002021Response to Carlson.Authorship 1027222234347287Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Giordano SH, Meyer LACancerFactors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States. Cancer. 2021 Nov 15; 127(22):4151-4160.Cancer2021-08-04T00:00:002021Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.Authorship 10296762634518313Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GBClinical cancer research : an official journal of the American Association for Cancer ResearchPhase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365.Clin Cancer Res2021-09-13T00:00:002021Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.Authorship 10384603Authorship 1038844235297648Huepenbecker SP, Zhao H, Sun CC, Fu S, He W, Giordano SH, Meyer LAJCO clinical cancer informaticsAlgorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data. JCO Clin Cancer Inform. 2022 03; 6:e2100187.JCO Clin Cancer Inform2022-03-01T00:00:002022Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.35331992Huepenbecker SP, Sun CC, Fu S, Zhao H, He W, Primm K, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyTemporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Int J Gynecol Cancer. 2022 07 04; 32(7):899-905.Int J Gynecol Cancer2022-07-04T00:00:002022Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States.Authorship 1044953335500609Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LAAmerican journal of obstetrics and gynecologyMedicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol. 2022 09; 227(3):482.e1-482.e15.Am J Obstet Gynecol2022-04-29T00:00:002022Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.Authorship 1046476235606067Gershenson DM, Sun CC, Westin SN, Eyada M, Cobb LP, Nathan LC, Sood AK, Malpica A, Hillman RT, Wong KKGynecologic oncologyThe genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes. Gynecol Oncol. 2022 06; 165(3):560-567.Gynecol Oncol2022-03-30T00:00:002022The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.Authorship 1051353435871117Primm KM, Huepenbecker SP, Zhao H, Sun CC, Hernandez DC, Meyer LA, Chang SAmerican journal of preventive medicineImpacts of Medicaid Expansion on Stage at Cancer Diagnosis by Patient Insurance Type. Am J Prev Med. 2022 Dec; 63(6):915-925.Am J Prev Med2022-07-21T00:00:002022Impacts of Medicaid Expansion on Stage at Cancer Diagnosis by Patient Insurance Type.Authorship 10600283Authorship 10593852Authorship 10567777Authorship 10602293Authorship 1062391236137845Gershenson DM, Cobb LP, Westin SN, Zhang Y, Jazaeri A, Malpica A, Sun CCGynecologic oncologyContemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival. Gynecol Oncol. 2022 11; 167(2):139-145.Gynecol Oncol2022-09-20T00:00:002022Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.36481644Sidey-Gibbons CJ, Sun C, Schneider A, Lu SC, Lu K, Wright A, Meyer LScientific reportsPredicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data. Sci Rep. 2022 12 08; 12(1):21269.Sci Rep2022-12-08T00:00:002022Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.36310311Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LAAnnals of surgical oncologyMedicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis. Ann Surg Oncol. 2023 Mar; 30(3):1508-1519.Ann Surg Oncol2022-10-30T00:00:002022Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis.36356982Prescott LS, Vergote I, Sun CC, Bodurka DC, Coleman RLInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyTransfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort. Int J Gynecol Cancer. 2023 01 03; 33(1):1-9.Int J Gynecol Cancer2023-01-03T00:00:002023Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort.36166208Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Rauh-Hain JA, Fleming ND, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyAssociation between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. Int J Gynecol Cancer. 2022 09 06; 32(9):1153-1163.Int J Gynecol Cancer2022-09-06T00:00:002022Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.Authorship 1064782536863760Vranes C, Zhao H, Noer MC, Fu S, Sun CC, Harrison R, Ramirez PT, H?gdall CK, Giordano SH, Meyer LAInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietySecondary validation of an ovarian cancer-specific comorbidity index in a US population. Int J Gynecol Cancer. 2023 05 01; 33(5):749-754.Int J Gynecol Cancer2023-05-01T00:00:002023Secondary validation of an ovarian cancer-specific comorbidity index in a US population.Authorship 10838411938009662Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AACancerRandomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer. 2024 04 01; 130(7):1061-1071.Cancer2023-11-27T00:00:002023Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.Authorship 1089510238377761Suidan RS, Sun CC, Schneider AK, Lu KH, Giordano SH, Meyer LAGynecologic oncologyDetermination of quality of life-related health utilities for surgical complications in ovarian cancer. Gynecol Oncol. 2024 Feb 19; 185:101-107.Gynecol Oncol2024-02-19T00:00:002024Determination of quality of life-related health utilities for surgical complications in ovarian cancer.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor24905618Sun C, Brown AJ, Jhingran A, Frumovitz M, Ramondetta L, Bodurka DCInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPatient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer. 2014 Jul; 24(6):1077-84.Int J Gynecol Cancer2014-07-01T00:00:002014Patient preferences for side effects associated with cervical cancer treatment.